KA
CTVA icon

Keene & Associates’s Corteva CTVA Stock Holding History

Keene & Associates’s Portfolio CTVA Stock Details CTVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$888K Buy
15,586
+195
+1% +$11.5K 0.71% 35
2024
Q3 		$905K Sell
15,391
-128
-0.8% -$6.99K 0.69% 35
2024
Q2 		$837K Buy
15,519
+882
+6% +$48.6K 0.68% 34
2024
Q1 		$844K Buy
14,637
+820
+6% +$42.4K 0.63% 38
2023
Q4 		$662K Buy
13,817
+2,358
+21% +$112K 0.55% 42
2023
Q3 		$586K Buy
11,459
+1,096
+11% +$58K 0.47% 40
2023
Q2 		$594K Sell
10,363
-275
-3% -$16.1K 0.46% 39
2023
Q1 		$642K Buy
10,638
+371
+4% +$22.7K 0.5% 39
2022
Q4 		$603K Sell
10,267
-829
-7% -$52.5K 0.54% 35
2022
Q3 		$634K Sell
11,096
-670
-6% -$39K 0.58% 35
2022
Q2 		$637K Sell
11,766
-1,359
-10% -$78.9K 0.6% 35
2022
Q1 		$754K Sell
13,125
-263
-2% -$13.4K 0.62% 36
2021
Q4 		$633K Buy
+13,388
New +$610K 0.55% 37

Other funds holding CTVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Keene & Associates's CTVA Position: Q4 2024 in Review

Keene & Associates increased its Corteva (CTVA) stake by 1.3% in Q4 2024, buying an estimated $11.5K and bringing the position to 15,586 shares worth $888K. The position accounts for 0.71% of the portfolio, ranked #35.

Keene & Associates first reported a position in CTVA in Q4 2021 and has held it in 13 quarters since. The position peaked at $905K in Q3 2024. 1,299 funds tracked by Wall St. Rank hold CTVA as of Q4 2024.

  • Keene & Associates held 15,586 shares of Corteva worth $888K as of Q4 2024.
  • Keene & Associates bought 195 Corteva shares in Q4 2024, an estimated $11.5K.
  • Corteva made up 0.71% of Keene & Associates's portfolio in Q4 2024, its #35 holding.
  • Keene & Associates first reported a position in Corteva in Q4 2021 and has held it in 13 quarters since.
  • Keene & Associates's Corteva position peaked at $905K in Q3 2024.
  • 1,299 funds tracked by Wall St. Rank held Corteva as of Q4 2024.

Based on Keene & Associates's 13F filing for Q4 2024, filed 3 Feb 2025.